Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.1.2 (
glutamate dehydrogenase
)
4,380
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Succinate dehydrogenase (SDH) and
glutamate dehydrogenase
(
GDH
) were determined parallel to the tetrazolium salts p-
DNTT
, NBT and TNBT under different conditions using sagittal brain sections of newborn and 3 till 100-day-old rats. Under conventional incubation conditions for SDH (37 degrees C, 30 min), the tetrazolium salts p-
DNTT
stained more intensely than NBT or TNBT. Decrease of the final concentration of tetrazolium salts from 1.2 mmol/l to 0.6 mM effected a considerable increase of p-
DNTT
formazan development. Using NBT or TNBT, the formazan formation was significantly smaller. In contrast to SDH the demonstration of
GDH
activity under incubations conditions mentioned is unsatisfactory at any rate. Preservation of mitochondria during the preparation and incubation procedure improved evidently the quality of the
GDH
-demonstration, especially by use of p-
DNTT
. The formazan of p-
DNTT
was formed to be amorphous and was confined exclusively to enzyme containing compartments, whereas formazanes of the NBT and TNBT spread out more diffusely.
...
PMID:[Improved demonstration of topochemical dehydrogenase in the CNS with a nitro-monotetrazolium salt]. 642 53